标题
Tiotropium/Olodaterol: A Review in COPD
作者
关键词
-
出版物
DRUGS
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2019-05-23
DOI
10.1007/s40265-019-01133-w
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Dual bronchodilation with tiotropium/olodaterol further reduces activity-related breathlessness versus tiotropium alone in COPD
- (2019) Franҫois Maltais et al. EUROPEAN RESPIRATORY JOURNAL
- Effects of baseline symptom burden on treatment response in COPD
- (2019) Fernando J Martinez et al. International Journal of Chronic Obstructive Pulmonary Disease
- Long-term cost-effectiveness of the fixed-dose combination of tiotropium plus olodaterol based on the DYNAGITO trial results
- (2019) Martine Hoogendoorn et al. International Journal of Chronic Obstructive Pulmonary Disease
- Improving usability and maintaining performance: human-factor and aerosol-performance studies evaluating the new reusable Respimat inhaler
- (2019) Rajiv Dhand et al. International Journal of Chronic Obstructive Pulmonary Disease
- Effect of Bronchodilation and Exercise Training with Behavior Modification on Exercise Tolerance and Downstream Effects on Symptoms and Physical Activity in COPD
- (2018) Thierry Troosters et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- β-Blockers in COPD
- (2018) François Maltais et al. CHEST
- Efficacy of tiotropium/olodaterol on lung volume, exercise capacity, and physical activity
- (2018) Masakazu Ichinose et al. International Journal of Chronic Obstructive Pulmonary Disease
- Tiotropium/olodaterol versus tiotropium in Japanese patients with COPD: results from the DYNAGITO study
- (2018) Masakazu Ichinose et al. International Journal of Chronic Obstructive Pulmonary Disease
- Tiotropium and olodaterol in the prevention of chronic obstructive pulmonary disease exacerbations (DYNAGITO): a double-blind, randomised, parallel-group, active-controlled trial
- (2018) Peter M A Calverley et al. Lancet Respiratory Medicine
- Safety of tiotropium/olodaterol in chronic obstructive pulmonary disease: pooled analysis of three large, 52-week, randomized clinical trials
- (2018) Gary T. Ferguson et al. RESPIRATORY MEDICINE
- Evaluation of the preference, satisfaction and correct use of Breezhaler® and Respimat® inhalers in patients with chronic obstructive pulmonary disease – INHALATOR study
- (2018) Maria Vera Cruz de Oliveira et al. RESPIRATORY MEDICINE
- Effects of combined tiotropium/olodaterol on inspiratory capacity and exercise endurance in COPD
- (2017) Denis E. O'Donnell et al. EUROPEAN RESPIRATORY JOURNAL
- Long-term general and cardiovascular safety of tiotropium/olodaterol in patients with moderate to very severe chronic obstructive pulmonary disease
- (2017) Roland Buhl et al. RESPIRATORY MEDICINE
- Lung function and long-term safety of tiotropium/olodaterol in East Asian patients with chronic obstructive pulmonary disease
- (2017) Chunxue Bai et al. International Journal of Chronic Obstructive Pulmonary Disease
- The impact of dual bronchodilation on cardiovascular serious adverse events and mortality in COPD: a quantitative synthesis
- (2017) Paola Rogliani et al. International Journal of Chronic Obstructive Pulmonary Disease
- Effect of tiotropium and olodaterol on symptoms and patient-reported outcomes in patients with COPD: results from four randomised, double-blind studies
- (2017) Gary T. Ferguson et al. npj Primary Care Respiratory Medicine
- A Systematic Review With Meta-Analysis of Dual Bronchodilation With LAMA/LABA for the Treatment of Stable COPD
- (2016) Luigino Calzetta et al. CHEST
- Chronic obstructive pulmonary disease exacerbation and inhaler device handling: real-life assessment of 2935 patients
- (2016) Mathieu Molimard et al. EUROPEAN RESPIRATORY JOURNAL
- Patients’ perspectives and preferences in the choice of inhalers: the case for Respimat® or HandiHaler®
- (2016) P.N. Richard Dekhuijzen et al. Patient Preference and Adherence
- Cost-effectiveness and budget impact of the fixed-dose dual bronchodilator combination tiotropium–olodaterol for patients with COPD in the Netherlands
- (2016) Job van Boven et al. International Journal of Chronic Obstructive Pulmonary Disease
- A cross-sectional study to assess inhalation device handling and patient satisfaction in COPD
- (2016) Marc Miravitlles et al. International Journal of Chronic Obstructive Pulmonary Disease
- Efficacy and safety of tiotropium + olodaterol maintenance treatment in patients with COPD in the TONADO® and OTEMTO® studies: a subgroup analysis by age
- (2016) Gary Ferguson et al. International Journal of Chronic Obstructive Pulmonary Disease
- The lung function profile of once-daily tiotropium and olodaterol via Respimat® is superior to that of twice-daily salmeterol and luticasone propionate via Accuhaler® (ENERGITO® study)
- (2016) Kai Michael Beeh et al. International Journal of Chronic Obstructive Pulmonary Disease
- The efficacy and safety of combined tiotropium and olodaterol via the Respimat® inhaler in patients with COPD: results from the Japanese sub-population of the Tonado® studies
- (2016) Masakazu Ichinose et al. International Journal of Chronic Obstructive Pulmonary Disease
- Development of an enhanced health-economic model and cost-effectiveness analysis of tiotropium + olodaterol Respimat® fixed-dose combination for chronic obstructive pulmonary disease patients in Italy
- (2016) Carl Selya-Hammer et al. Therapeutic Advances in Respiratory Disease
- Comparative efficacy of fixed-dose combinations of long-acting muscarinic antagonists and long-acting β2-agonists: a systematic review and network meta-analysis
- (2016) Max Schlueter et al. Therapeutic Advances in Respiratory Disease
- Efficacy of Tiotropium + Olodaterol in Patients with Chronic Obstructive Pulmonary Disease by Initial Disease Severity and Treatment Intensity: A Post Hoc Analysis
- (2015) Gary T. Ferguson et al. ADVANCES IN THERAPY
- New combination bronchodilators for chronic obstructive pulmonary disease: current evidence and future perspectives
- (2015) Dave Singh BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Tiotropium/Olodaterol: A Review in COPD
- (2015) Sohita Dhillon DRUGS
- Olodaterol: A Review of Its Use in Chronic Obstructive Pulmonary Disease
- (2015) Emma D. Deeks DRUGS
- Tiotropium and olodaterol fixed-dose combinationversusmono-components in COPD (GOLD 2–4)
- (2015) Roland Buhl et al. EUROPEAN RESPIRATORY JOURNAL
- The 24-h lung-function profile of once-daily tiotropium and olodaterol fixed-dose combination in chronic obstructive pulmonary disease
- (2015) Kai-Michael Beeh et al. PULMONARY PHARMACOLOGY & THERAPEUTICS
- Tiotropium + olodaterol shows clinically meaningful improvements in quality of life
- (2015) Dave Singh et al. RESPIRATORY MEDICINE
- Tiotropium Respimat® Soft Mist™ Inhaler: A Review of Its Use in Chronic Obstructive Pulmonary Disease
- (2014) Gillian M. Keating DRUGS
- Effect of Switching Tiotropium HandiHaler® to Respimat® Soft Mist™ Inhaler in Patients with COPD: The Difference of Adverse Events and Usability Between Inhaler Devices
- (2012) Yuka Asakura et al. Journal of Aerosol Medicine and Pulmonary Drug Delivery
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search